Oral Wegovy is FDA-approved for weight loss in adults with obesity or overweight and at least one weight-related condition
A typical starting dose is 2.5 mg twice daily
Improved Liver Function With the liver being a critical organ in fat metabolism, improving its function can significantly enhance weight loss efforts
Its approved for people with obesity (a body mass index [BMI] of 30 or more) or overweight (a BMI of 27 or more) with at least 1 weight-related health condition such as high cholesterol, high blood pressure, or type 2 diabetes
Week 5 reassessment: Check inflammatory markers (CRP, ESR, relevant condition-specific markers)
So do we think that these are going to be waived off as rare occurrences that happen, maybe based on other factors, or that they would be actually taken seriously